SCHEMBL7739637

SCHEMBL7739637

Nc1cccc(OCCOc2ccccc2)c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.67
TSHR P16473 1/20 0.62
CYP3A4 P08684 2/20 0.62
TP53 P04637 1/20 0.62
KCNA3 P22001 1/20 0.54
TAAR1 Q96RJ0 1/20 0.54
ALDH1A1 P00352 2/20 0.52
APP P05067 1/20 0.51
LTA4H P09960 1/20 0.50
F2 P00734 1/20 0.50
PLG P00747 1/20 0.50
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
C1S P09871 1/20 0.50
PRSS3 P35030 1/20 0.50
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
RECQL P46063 1/20 0.48
MAOA P21397 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29502076 0.94 CYP3A4 (0.69) MAOBTSHRCYP3A4TP53ALDH1A1
SCHEMBL3791936 0.94 CYP3A4 (0.69) MAOBTSHRCYP3A4TP53ALDH1A1
SCHEMBL3979591 0.92 TSHR (0.74) MAOBTSHRCYP3A4TP53KCNA3
SCHEMBL29218367 0.90 TSHR (0.61) MAOBTSHRCYP3A4TP53ALDH1A1
SCHEMBL31286544 0.90 TSHR (0.61) MAOBTSHRCYP3A4TP53ALDH1A1
SCHEMBL9064380 0.88 TSHR (0.62) MAOBTSHRCYP3A4TP53ALDH1A1
SCHEMBL29437009 0.87 TSHR (0.79) MAOBTSHRCYP3A4TP53KCNA3
SCHEMBL6756802 0.87 TSHR (0.72) MAOBTSHRCYP3A4TP53ALDH1A1
SCHEMBL29437038 0.87 TSHR (0.72) MAOBTSHRCYP3A4TP53ALDH1A1
SCHEMBL441825 0.87 TSHR (0.79) MAOBTSHRCYP3A4TP53KCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420403-B1 INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE, TRANSPLANT REJECTION AND AUTOIMMUNE DISEASES. BRISTOL-MYERS SQUIBB COMPANY 2002-07-16 US disclosed